Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metal-regulatory transcription factor 1 (MTF-1) is a highly conserved, zinc-dependent transcription factor that serves as the primary cellular sensor for heavy metal ions and oxidative stress. It plays a critical role in maintaining metal homeostasis by inducing the expression of metallothioneins and metal transporters in response to elevated levels of zinc, copper, cadmium, and other metals. Beyond its homeostatic functions, MTF-1 is essential for embryonic liver development and participates in cellular adaptive responses to hypoxia and oxidative damage. In clinical contexts, MTF-1 is often dysregulated in various malignancies, including hepatocellular carcinoma and lung cancer, where it can promote tumor progression, angiogenesis, and resistance to chemotherapy. Therapeutic strategies targeting MTF-1 involve the use of metal-modulating agents, such as zinc chelators or ionophores, which alter the factor's transcriptional activity to inhibit cancer cell proliferation or mitigate metal-induced toxicity. As a central regulator of the cell's stress response, MTF-1 represents a significant target for drug development in oncology and environmental toxicology.
MTF-1 is a zinc-finger transcription factor that functions as a primary sensor for heavy metal ions, particularly zinc. Upon activation by metal binding, MTF-1 translocates from the cytoplasm to the nucleus, where it binds to metal-responsive elements (MREs) in the promoter regions of target genes. This binding induces the transcription of genes such as metallothioneins (MT1, MT2) and zinc transporters (ZnT1), which are essential for metal detoxification, homeostasis, and protection against oxidative stress. Drugs targeting MTF-1 typically modulate intracellular metal levels (e.g., zinc ionophores or chelators), thereby indirectly regulating its transcriptional activity to influence tumor growth, angiogenesis, and drug resistance.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metal-regulatory transcription factor 1 (MTF-1) (MTF-1).